Enfortumab Vedotin–Associated Toxic Epidermal Necrolysis-like Toxic Erythema of Chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enfortumab Vedotin–Associated Toxic Epidermal Necrolysis-like Toxic Erythema of Chemotherapy

Published:2022-07-19 Issue:12 Volume:44 Page:933-935
ISSN:0193-1091
Container-title:The American Journal of Dermatopathology
language:en
Short-container-title:

Author:

Birmingham Suzanne W.,Moon Deborah J.,Kraus Christina N.,Lee Bonnie A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Dermatology,General Medicine,Pathology and Forensic Medicine

Reference8 articles.

1. Postmarketing cases of enfortumab vedotin-associated skin reactions reported as Stevens-Johnson syndrome or toxic epidermal necrolysis;Nguyen;JAMA Dermatol.,2021

2. Case report: enfortumab vedotin for metastatic urothelial carcinoma: a case series on the clinical and histopathologic spectrum of adverse cutaneous reactions from fatal stevens-johnson syndrome/toxic epidermal necrolysis to dermal hypersensitivity reaction;Viscuse;Front Oncol.,2021

3. A rare presentation of enfortumab vedotin-induced toxic epidermal necrolysis;Francis;JAAD Case Rep.,2021

4. Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer;Lattanzio;Oncogenesis.,2014

5. Toxic epidermal necrolysis-like toxic erythema of chemotherapy: 2 illustrative cases;Lu;JAAD Case Rep.,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dermatologic toxicities of antibody-drug conjugates;Journal of the American Academy of Dermatology;2024-08

2. Toxic Skin Reactions Should Be Differentiated from Allergic Reactions to Chemotherapeutic Drugs in Children: A Case Series and Review of the Literature;Dermatitis®;2024-06-01

3. Enfortumab vedotin toxic epidermal necrolysis–like blistering dermatosis: A case series and review of the literature;JAAD Case Reports;2024-01

4. Cutaneous adverse reactions resulting from targeted cancer therapies: histopathologic and clinical findings;Human Pathology;2023-10

5. Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database;Frontiers in Pharmacology;2023-04-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3